Acute liver failure due to natural killer-like T-cell leukemia/lymphoma: A case report and review of the Literature

Por Dellon, Evan S, Morris, Shannon R, Tang, Wozhan, Dunphy, Cherie H, Russo, Mark W
Publicado em 2006

Phase I/II study of ADXS11-001 or MEDI4736 immunotherapies alone and in combination, in patients with recurrent/metastatic cervical or human papillomavirus (HPV)-positive head and...

Por Cohen, Ezra EW, Moore, Kathleen N, Slomovitz, Brian M, Chung, Christine H, Anderson, Matthew L, Morris, Shannon R, Mauro, David, Burtness, Barbara
Publicado no J Immunother Cancer (2015)

The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma

Por Spencer, Andrew, Yoon, Sung-Soo, Harrison, Simon J., Morris, Shannon R., Smith, Deborah A., Brigandi, Richard A., Gauvin, Jennifer, Kumar, Rakesh, Opalinska, Joanna B., Chen, Christine
Publicado no Blood (2014)

A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pat...

Por Cheraghchi-Bashi, Azadeh, Parker, Christine A., Curry, Ed, Salazar, Jean-Frederic, Gungor, Hatice, Saleem, Azeem, Cunnea, Paula, Rama, Nona, Salinas, Cristian, Mills, Gordon B., Morris, Shannon R., Kumar, Rakesh, Gabra, Hani, Stronach, Euan A.
Publicado no Oncotarget (2015)